Unnamed: 0,patient_filename,t,text,type,n,cmem_n_reasoning,cmem_n_ans_str,cmem_n_num_update
1485,TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9,1,"FINAL PATHOLOGIC DIAGNOSIS. A. Surgical hardware, right breast, removal: - Implant identified, gross examination only. B. Breast, right, modified radical mastectomy: - Invasive ductal carcinoma, three separate foci measuring 2.8 cm (main. lesion) grade II/III, 0.7 cm (satellite #1) grade II/III and 1.1 cm (satellite. #2) grade I/III, in greatest dimension, surgical margins negative (see. pathologic parameters and comment below). - Ductal carcinoma in situ, intermediate grade, solid and papillary types,. surgical margins negative. - Uninvolved breast tissue with fibrocystic changes. - Previous biopsy sites present. - One of ten axillary lymph nodes involved by metastatic carcinoma (1/10). C. Lymph nodes, right axillary, excision: - Two lymph nodes, negative for carcinoma (0/2). Breast Pathologic Parameters. 1. Invasive carcinoma: A. Gross measurement: Three foci - 2.8 cm (main lesion). 0.7 cm (satellite #1). 1.1 cm (satellite #2). B. Composite histologic (modified SBR) grade: II/III (main and. satellite #1). I/II (satellite #2). C. Associated intraductal carcinoma in situ (DCIS): - Within main mass (forming <10% of tumor volume). 2. Surgical margins: - DCIS 5.0 mm from closest margin (posterior). - Invasive carcinoma 5.0 mm from closest margin (posterior). - Additional margins widely free. 3. Blood vessel and lymphatic invasion: Present in breast parenchyma. 4. Nipple: Unremarkable. 5. Skin: Uninvolved. 6. Skeletal muscle: Absent. 7. Axillary lymph nodes: - Current specimen. One of twelve lymph nodes involved by metastatic carcinoma (1/12). - Size of largest metastatic deposit: 1.0 cm. - Extranodal extension: Present (1.0 mm; largest focus). - Sentinel node biopsies (. - Two of five sentinel lymph nodes involved by metastatic carcinoma. (2/5). - Size of largest metastatic deposit: 1.0 cm. - Extranodal extension: Absent. - Total: Three of seventeen lymph nodes involved by metastatic carcinoma. (3/17). 8. Special studies (see. - ER: Strong expression in >90% of invasive tumor nuclei (all three lesions). - PR: Strong expression in >90% of invasive tumor nuclei (all three lesions). - HER2 antigen (FISH): - Main lesion: Non-amplified (ratio: 1.2). - Satellite #1: Non-amplified (ratio: 1.5). - Satellite #2: (IHC): negative (0 - 1+). - Ki67: - Main lesion: 20%. - Satellite #1: 20%. - Satellite #2: 10%. 9. pTNM (AJCC, 7th edition, 2010): pT2(m), N1a, MX. Effective. this Checklist utilizes the 7th edition TNM staging. system for breast of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Clinical History: Right Breast Cancer. Comment. P63 and myosin heavy chain immunohistochemical stains are performed and show a. loss of myoepithelium associated with the invasive component. Specimens Received: A: Right breast implant. B: Right breast with axillary contents. C: Additional nodes right axilla. Gross Description: The specimens are received in three containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'right breast implant'. Received in container is a 14 x 14 x 4.5 cm white, round, plastic hardware. filled with liquid material. Gross photograph is taken. The specimen is for. gross evaluation only. B. The second container is additionally identified as, 'right breast with. axillary contents'. Received fresh and placed in formalin is a 268 gm simple. mastectomy specimen. There is a 15 x 6.5 cm capsule pocket implant in posterior. inferior aspect of specimen. The specimen isoriented with a double short suture. designating the superior aspect and a double long suture designating the lateral. aspect. The breast measures 15.5 cm from medial to lateral, 14 cm from superior. to inferior, and 2.3 cm from anterior to posterior. On the anterior surface is. 13.3 X 5.3 cm yellow-tan ellipse of skin with a 4.8 x 3.8 cm areola and a 1.3 x. 1 cm raised nipple. The nipple-areolar complex reveals no evidence of. ulceration or retraction. The specimen is inked as follows: anterior-superior - blue;. anterior-inferior - green;. posterior - black. The specimen is serially sectioned from lateral (slice #1) to medial into 13. slices to reveal a 2.8 x 1.8 x 1.5 cm grey-tan, irregular-shaped, rubbery lesion. (lesion #1) in slices #6 through #8, which is 0.3 cm from deep margin. There is. a 1.1 X 1.0 X 0.3 cm pink-tan, oval nodule (lesion #2) in slice #7, which abuts. the capsule pocket and less than 0.5 cm from lesion #1. There is a hemorrhagic. area of dense parenchyma measuring 2.8 X 1.5 X 1 cm in slices #9 through #10,. which is 1.2 cm from the deep margin. The remainder of the specimen consists of. approximately 30% dense gray-white fibrous breast parenchyma and 70% lobulated. yellow adipose tissue. No additional masses or nodules are grossly identified. Multiple gray-tan, rubbery axillary lymph nodes ranging from 0.3-1.2 cm are. dissected. Block summary: B1: nipple. B2: skin adjacent to lesion #1, slice 7. B3: Lesion #1, slice 6. B4: Lesion #1, slice 7. B5: Lesion #1, slice 8. B6: Lesion #2 and adjacent lesion #1, slice 7. B7: Lesion #3, slice 9. B8: Lesion #3, slice 10. B9: upper-outer quadrant slice 4. B10: lower-outer quadrant slice 5. B11: upper-inner quadrant slice 8. B12: lower-inner quadrant slice 11. B13: 4 lymph nodes. B14-B15: 3 lymph nodes. B16: One lymph node, trisected. B17: One lymph node, bisected. B18-B19: One lymph node, serial section. B20: 4 lymph nodes. C. The third container is additionally identified as, 'additional nodes right. axilla'. Received fresh and placed in formalin are 2 yellow-tan, soft tissue. fragments measuring 0.5-1.5, which are entirely submitted as C1. MD, PhD.",BRCA,1,"The N stage is determined by the involvement of lymph nodes. In this report, one out of ten axillary lymph nodes is involved by metastatic carcinoma (1/10). This corresponds to N1 stage according to the AJCC 7th edition staging system for breast cancer.",N1,0.0
891,TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754,0,"Final Diagnosis. Breast, right, excision: Infiltrating lobular carcinoma, Nottingham I (of. III) forming a 1.6 x 1.5 x 1.3 cm mass (AJCC pT1c) The carcinoma shows. ductular involvement. No angiolymphatic involvement is present. The. surgical resection margins, including the separately submitted margins,. are negative for tumor. Lymph nodes, right sentinel, excision: Negative for tumor. Immunohistochemical cytokeratin stain was performed on the paraffin. embedded sentinel lymph node tissue and confirms the H&E impression. The infiltrating breast carcinoma is positive for estrogen receptor and. negative for progesterone receptor.",BRCA,0,"The report states that the right sentinel lymph node excision is negative for tumor, and there is no mention of clinically positive nodes. This indicates that there is no regional lymph node metastasis, which corresponds to N0.",N0,1.0
954,TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7,0,"AP Surgical Pathology: Additional Info. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Sentinel node #1, hot (AF1-3) "", received for frozen section are three. lymph node candidates. One lymph node is bisected and submitted for frozen. section as AF1-AF2, and the remnant sections are submitted in blocks A1-2. Two additional lymph nodes are submitted for frozen section as AF3, and the. remnant is submitted as block A3. B. ""Axillary fat"", received in formalin is a 11.3 x 4 x 1.5 cm fragment of. yellow-tan adipose tissue which is dissected to reveal one lymph node. candidate measuring 0.8 x 0.7 x 0.5 cm, which is submitted entirely in block. B1. C. ""Left breast cancer, two clips medial, one clip inferior, long stitch. lateral, short stitch superior"", received in formalin is a 8 cm medial to. lateral, 7 cm superior to inferior, 2.7 cm anterior to posterior lumpectomy. specimen inked as follows: superior-yellow, inferior-red, anterior-blue and. posterior-black. The specimen is sectioned from medial to lateral to reveal a. 2.0 x 1.5 x 1 cm mass lesion located 0.4 cm from the posterior margin, 0.7 cm. from the anterior margin, 2.7 cm from the medial margin, 2.7 cm from the. lateral margin, 1.3 cm from the superior margin and 3.2 cm from the superior. margin. The remainder of the breast tissue demonstrates fibrofatty lobulated. adipose tissue that is otherwise grossly unremarkable. Sections are submitted. as follows per the block diagram: BLOCK SUMMARY: C1-. medial edge. C2-4. representative medial breast. C5-28 mass submitted entirely. C29-31 representative lateral breast. C32-34 lateral edge. D. ""Superior medial margin"", received in formalin is a 7.2 x 6.4 x 2.3 cm. fragment of adipose tissue with a stitch marking final margin. The final. margin is inked blue and the opposite margin is inked black. Every other. section is submitted in blocks D1-10. E. ""Medial and superior margin"", received in formalin is a 5.5 x 3.5 x 2.2 cm. fragment of yellow-tan adipose tissue with a stitch in place marking the final. margin. The stitched margin is inked blue, and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks E1-12. F. ""Inferior to lateral margin"", received in formalin is a 6.5 x 5.2 x 2.1 cm. fragment of yellow-tan adipose tissue with a suture marking the final. margin. The final margin is inked blue and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks F1-11. G. ""Anterior skin"", received in formalin is a 7.5 x 5 x 2 cm unoriented. aggregate of brown skin with subcutaneous tissue that is grossly. unremarkable. Representative sections are submitted in blocks G1-3. INTRA OPERATIVE CONSULTATION: A. ""Sentinel node #1, hot and blue"": AF1-2 (one lymph node candidate, bisected) -positive for carcinoma. AF3 (two lymph node candidates) -negative for malignancy. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Partial mastectomy, sentinel lymph node biopsy. PATHOLOGIC STAGE (AJCC. Edition) : pT1c pN1a (sn) pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""SENTINEL LYMPH NODE #1"" (BIOPSY) : METASTATIC ADENOCARCINOMA IN ONE OF THREE LYMPH NODES (1/3). SIZE OF METASTASIS: 5 MILLIMETERS. EXTRANODAL INVASION: ABSENT. B. ""AXILLARY FAT"" (EXCISION) : ONE LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1) . SEE COMMENT. COMMENT: The specimen is re-examined and only one lymph node is identified. C. ""LEFT BREAST CANCER"" (PARTIAL MASTECTOMY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. GROSS TUMOR SIZE: 2 x 1.5 X 1 CM. SIZE OF INVASIVE COMPONENT: 2.0 CM. LYMPHATIC/VASCULAR INVASION: ABSENT. MULTIFOCAL TUMOR: ABSENT. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: CRIBRIFORM. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. NECROSIS: ABSENT. DCIS EXTENDING OUTSIDE INVASIVE TUMOR MASS: ABSENT. SIZE OF IN-SITU CARCINOMA: NOT APPLICABLE. STATUS OF NON-NEOPLASTIC BREAST TISSUE: INTRADUCTAL PAPILLOMA, RECENT. NEEDLE CORE BIOPSY SITE. SIZE OF BIOPSY: 8 X 7 x 2.7 CM. MICROCALCIFICATIONS: ABSENT. SURGICAL MARGIN STATUS: NEGATIVE (GREATER THAN 2 MM) . ESTROGEN/PROGESTERONE RECEPTOR, CELL CYCLE, EGFR AND HER2/NEU ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: C14. RESULTS WILL BE ISSUED IN SEPARATE REPORT FROM. D. ""SUPERIOR MEDIAL MARGIN, LEFT BREAST"" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. E. ""MEDIAL AND SUPERIOR MARGIN, LEFT BREAST"" (RE-EXCISION). BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. F. ""INFERIOR TO LATERAL"" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. G. ""ANTERIOR SKIN"" (BIOPSY) : SKIN AND SUBCUTANEOUS TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN IS NEGATIVE FOR MALIGNANCY. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .",BRCA,1,The report states that there is metastatic adenocarcinoma in one of three lymph nodes (1/3) from the sentinel lymph node biopsy. This indicates that the N stage is N1 as per the rule: N1 indicates metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.,N1,2.0
503,TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST LUMPECTOMY. B: RIGHT AXILLARY NODE DISSECTION. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED (G2). NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei=2, Mitoses= 2; mitotic count 10 per 10 HPF at. 20x power-0.5 field diameter). TUMOR SIZE (GREATEST DIMENSION) : 1.9 CM (measured microscopically) . TUMOR NECROSIS: ABSENT. MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: ABSENT. MARGINS : - INVASIVE CARCINOMA PRESENT 1.2 CM FROM ANTERIOR MARGIN. DUCTAL CARCINOMA IN SITU PRESENT 0.5 CM FROM INFERIOR MARGIN. INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, CRIBIFORM TYPE, LOW. NUCLEAR GRADE. LYMPH NODES: FIVE OF SIXTEEN POSTIVE FOR TUMOR. (see specimen B). SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: ABSENT. ESTROGEN RECEPTORS: POSITIVE. (see. PROGESTERONE RECEPTORS NEGATIVE. (see. HER 2 NEU by IHC: NEGATIVE. (see. PATHOLOGIC STAGE: pT1c N2a Mx. ADDITIONAL PATHOLOGIC CHANGES: BENIGN FIBROCYSTIC CHANGES. B. SOFT TISSUE, RIGHT AXILLA, LYMPH NODE DISSECTION: - FIVE OF SIXTEEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old female with 2.0 cm right breast mass found on routine. mammagram. Patient was also found to have two lymph nodes seen. largest 1.5 cm, BIRIDS-5 Ultrasound guided biopsy of breast mass showed. Grade I Invasive Ductal Carcinoma with DCIS and FNA of axillary lymph node. showing metastatic carcinoma from primary breast on. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""RIGHT BREAST LUMPECTOMY"" is an irregular, oblong portion of. soft tissue oriented with a short stitch superior and a long stitch. medial. The specimen measures 14.0 cm in medial to lateral, 7.0 cm. superior to inferior, and 2.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 8.5 x 2.2 cm and is otherwise. unremarkable. The specimen is inked as follows superior = blue, inferior. = green, medial = red, lateral = yellow, anterior = orange, and posterior. = black. Serial sections reveal a firm, pink-white, gray mass measuring. 3.3. x 2.2 x 1.5 cm. The mass is well circumscribed, and approaches the. margins as follows: 0.2 cm from the deep margin, 0.5 cm from the anterior. margin, 1.5 cm from the inferior margin, and 1.8 cm from the superior. margin. The remainder of the specimen is predominantly composed of. lobulated, yellow-tan, adipose tissue. The fibrous tissue comprises. 5%. of. the cut surface, and is tan-white, markedly dense, and otherwise. unremarkable. Representative sections are submitted as follows: Cassette Summary : A1: Mass. A2: Adjacent normal. A3: Skin. A4-A5: Additional sections adjacent to mass. A6-A9: Additional sections of mass. A10-12 Additional sections adjacent to A1 and A9. Matched sections of A1-A2 are submitted in. or CBCP protocol. The specimen was placed in formalin at. pm for a total time in. formalin for approximately 28 hours. B. Received fresh, labeled with the patient's name,. designated ""RIGHT AXILLARY NODE DISSECTION"" is an 11.0 x 8.0 x 2.5 cm. irregular, unoriented portion of soft tissue. Serial sectioning reveals. Y. Specimen # : GROSS DESCRIPTION (continued). 16 lymph nodes ranging in size from 0.7 x 0.7 x 0.5 cm to 4.0 x 2.0 x 1. . 0. cm. On sectioning, four of the lymph nodes show a firm, pink-tan, cut. surface consistent with metastatic involvement. The remaining lymph nodes. are pink-yellow and otherwise unremarkable. Representative sections are. submitted as follows: Cassette Summary : B1-B4: Largest lymph node. B5: Lymph node #1. B6: Lymph node #2. B7: Lymph node #3. B8: Lymph node #4. B9: One lymph node. B10: One lymph node. B11: One lymph node bisected. B12: One lymph node bisected. B13: One lymph node bisected. B14: Two lymph nodes, each bisected. B15: Four lymph nodes. Matched sections of B1, B5-B10 - are submitted in. or CBCP protocol.",BRCA,2,The report states that five out of sixteen lymph nodes are positive for tumor metastasis. This corresponds to N2 as it falls within the range of 4-9 positive lymph nodes.,N2,3.0
1138,TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C,1,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - left breast with axillary tissues. Material collected on: : Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTest™ by DAKO. Score = 2+, FISH verification recommended. Macroscopic description: Left breast sized 22 x 15 x 5 cm removed along with axillary tissues sized 13 x 7.5 x 1.5 cm and a skin flap of 19 x 11 cm. Retracted nipple. Tumour sized 2.5 x 2 x 2.8 cm found on the boundary of lower quadrants, located 3.5 cm from the lower. boundary, 0.4 cm from the base and 3 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG2 (2+2+3/21 mitoses/10 HPF - visual area 0.57mm). Glandular tissue showing. lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH 1. AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No III/XXIII). Infiltratio capsulae lymphonodorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodosi axillae (No III/XXIII) (NHG2, pT2, pNIa). Cancer metasta ° of axillary lymph nodes (No III/XXIII) (NHG2, pT2, pNIa). S. Examination: Histopathological examination. page 2 / 2. Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.",BRCA,1,"The report mentions 'Metastases carcinomatosae in lymphonodis (No III/XXIII)', which indicates metastasis in 1-3 axillary lymph nodes. This corresponds to N1 stage according to the rules.",N1,4.0
1473,TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0,0,"FINAL PATHOLOGIC DIAGNOSIS. A. Breast, left; modified radical mastectomy: - Invasive ductal carcinoma, SBR grade 2, see parameters. - Ductal carcinoma in situ, intermediate grade, solid and cribriform types. with associated necrosis. - Surgical margins free of tumor. - Biopsy site changes. - Fourteen nodes, negative for carcinoma (0/14). - Nipple, areola, and skin without diagnostic abnormality. B. Breast, right; simple mastectomy: - Invasive ductal carcinoma, SBR grade 2, inferior-anterior of hematoma. cavity, see parameters. - Extensive ductal carcinoma in situ, intermediate grade, solid type, with. associated central necrosis. - Anterior-inferior margin positive for invasive carcinoma. - Attached skeletal muscle focally infiltrated by invasive carcinoma. (anterior-inferior). - Columnar cell change and adenosis. - Intraductal papilloma. - Nipple, areola, and skin without diagnostic abnormality. Breast Pathologic Parameters (Part A Left Breast). 1. Invasive carcinoma: A. Gross measurement: 1.9 X 1.5 X 1.5 cm. B. Composite histologic (modified SBR) grade: II. - Architecture: 2. - Nuclear grade: 3. - Mitotic count: 1. C. Associated intraductal carcinoma in situ (DCIS): - Within main mass (forming 10 % of tumor volume). - Extending away from main lesion. 2. Intraductal carcinoma: A. Gross or microscopic (specify) measurement: (5.2 cm, spanning 4 slices). B. Type: Cribriform and Solid. C. Nuclear grade: Intermediate. D. Associated features: Necrosis. 3. Excisional biopsy margins: Free of tumor. - DCIS 4 mm from posterior margin. - Invasive carcinoma 5 mm from posterior (closest) margin. 4. Blood vessel and lymphatic invasion: Not identified. 5. Nipple: unremarkable. 6. Skin: uninvolved. 7. Skeletal muscle: Focally present, negative for tumor. 8. Axillary lymph nodes: In combination with previous sentinel lymph node biopsy. (see. One of fifteen nodes positive for carcinoma (1/15). - Size of largest metastatic deposit: 18 mm. - Extranodal extension: present (2 mm; largest focus). 9. Special studies (see. - ER: Positive expression in >95% of invasive tumor nuclei. - PR: Positive expression in 80% of invasive tumor nuclei. - Her2/neu antigen (FISH): Non-amplified (1.02). 10. pTNM (AJCC, 7th edition, 2010): pT1cN1MX. Effective. this Checklist utilizes the 7th edition TNM staging. system for breast of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Breast Pathologic Parameters (Part B Right Breast). 1. Invasive carcinoma: A. Microscopic measurement: 1.5 cm. B. Composite histologic (modified SBR) grade: II. - Architecture: 3. - Nuclear grade: 2. - Mitotic count: 1. C. Associated intraductal carcinoma in situ (DCIS): - Within main mass (forming 50 % of tumor volume). - Extending away from main mass. 2. Intraductal carcinoma: A. Microscopic measurement: 6.1 cm, spanning over 5 slices, involving lower. inner and upper inner quadrants and extending anteriorly towards nipple. B. Type: Solid. C. Nuclear grade: Intermediate. D. Associated features: Necrosis and cancerization of lobules. 3. Excisional biopsy margins: Positive. - DCIS >3 mm from posterior and inferior (closest) margins. - Invasive carcinoma at inferior-anterior margin with infiltration of. attached skeletal muscle. 4. Blood vessel and lymphatic invasion: Suspicious. 5. Nipple: unremarkable;DCIS noted 5 mm from areolar complex. 6. Skin: uninvolved. 7. Skeletal muscle: Focus attached inferior-anterior infiltrated by carcinoma. 8. Axillary lymph nodes: Negative (Two sentinel nodes, negative for carcinoma. (0/2), see. 9. Special studies (see. - ER: Strong expression in >90% of invasive tumor nuclei. - PR: Strong expression in >90% of invasive tumor nuclei. - Her2/neu antigen (FISH): Non-amplified (1.04). 10. pTNM (AJCC, 7th edition, 2010): pT1cNO(sn)MX (pending review of imaging). Effective. this Checklist utilizes the 7th edition TNM staging. system for breast of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Clinical History: The patient is a. 'ear old female with malignant neoplasm of the breast. undergoing left modified radical mastectomy and right simple mastectomy. Comment. B. Stains for CKAE1/AE3 and myosin-heavy chain support extension of invasive. carcinoma into skeletal muscle at the inferior-anterior aspect of the breast. Findings were discussed with. Specimens Received: A: Left modified radicalmastectomy; mastectomy. B: Right simple mastectomy; partial mastectomy. Gross Description: Received are two containers, each labeled with the patient's name and medical. record number. A. Container A is further designated '1. Left modified radicalmastectomy;. mastectomy. The radiographic findings for this breast include an irreglarly. shaped mass measuring 1.4 X 1.2 X 1.9 cm and areas of heterogenous kinetics with. washout. The total extent of the abnormal enhancing is 2.8 X 2.3 X 1.9 cm. Received fresh and placed in formalin is a 468 gram mastectomy specimen. measuring 14.5 cm from medial to lateral, 17.5 cm from superior to inferior and. 3.7 cm from anterior to posterior. It has an axillary tail measuring 11 X 6.5. X. 1.5 cm. The skin measures 13.2 X 5 cm and an nipple areola complex measuring 3 X. 2.7 cm and a nipple measuring 1 X 1 cm. The specimen is inked as follows: posterior black, anterior-superior yellow, anterior-inferior green. It is. sliced into 11 slices to reveal a lesion that is present from slices 6 to 8 and. the lesion measures 1.9 X 1.5 cm and has a medial to lateral dimension of 1.5. cm. It focally abuts the deep margin and is 3 cm from the inferior margin and 9. cm from the superior margin. No other lesions or masses are identified. A. number of lymph node candidates are identified in the axillary tail, the largest. of which measures 2.5 X 2 X 1.8 cm. This large lymph node is sectioned to. reveal a central area of necrosis. Block Summary: A1-A3: lesion from slice 6. A2: superior to lesion. A3: inferior to lesion. A4: lesion in slice 7. A5: lesion in slice 8. A6: slice 5 next to lesion. A7: slice 9 next to lesion. A8: skin and nipple. A9: areola. A10: upper-inner quadrant from slice 2. A11: lower-inner quadrant from slice 4. A12: upper-outer quadrant from slice 7. A13: lower-outer quadrant from slice 7. A14: three lymph node candidates. A15: three lymph node candidates. A16: three lymph node candidates. A17: three lymph node candidates. A18: one lymph node candidate. A19: one lymph node candidate. A20-A21: largest lymph node candidate bisected. A22-A25: additional representative sections of axillary fat. B. Container B is further designated '2. Right simple mastectomy;. partial mastectomy. Received fresh and placed in formalin is a 350 gram. mastectomy specimen measuring 17 cm from medial to lateral, 13.5 from superior. to inferior, and 2.5 cm from anterior to posterior. There is a skin ellipse. measuring3 X 3.5 cm and an areola measuring 2.5 X 2.7 cm and a nipple measuring. 1 x 1 cm. It is sliced into 14 slices in which there is a hematoma cavity. measuring 1.5 X 1.5 x 3.1 cm found in slices 3, 4, 5 and 6. The cavity has a rim. of white-tan, firm tissue around it and the cavity is 1.1 cm from the deep. margin and 0.6 cm from the inferior margin. Also note that the deep margin is. inked red, the anterior-superior margin is inked blue and the anterior-inferior. margin is inked green. No other lesions or masses are identified. Block Summary: B1: lesion in slice 3. B2: superior to B1. B3: lesion in slice 4. B4: superior to B3. B5: lesion in slice 5. B6: superior to B5. B7: lesion in slice 6. B8: superior to B7. B9: slice 7 adjacent to lesion. B10: slice 2 adjacent to lesion. B11: upper-outer quadrant in slice 12. B12: lower-outer quadrant in slice 11. B13: upper-inner quadrant in slice 5. B14: lower-inner quadrant in slice 6. B15: skin and nipple. B16: areola. The specimen is inked as follows: posterior red, anterior-superior blue,. anterior inferior green. The tissue is fixed for at least six hours in NBF and no more than 72 hours.",BRCA,1,"The report indicates that for the left breast, 14 nodes were negative for carcinoma (0/14), and for the right breast, two sentinel nodes were negative for carcinoma (0/2). Therefore, the patient has no regional lymph node metastasis, which corresponds to N0 stage.",N0,5.0
1471,TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C,2,"FINAL PATHOLOGIC DIAGNOSIS. Mastectomy and sentinel lymph node biopsy,. A. Left axillary sentinel node #1: - Single lymph node, no tumor (0/1). B. Left axillary sentinel node #2: - Single lymph node, no tumor (0/1). C. Mastectomy, left breast: - Invasive ductal carcinoma, SRB grade II, with focal necrosis. - Ductal carcinoma in situ, high nuclear grade, solid type. - Focal Paget' S disease of the nipple. - Uninvolved breast parenchyma with focal flat epithelial atypia, columnar. cell change, ductal hyperplasia of usual type, intraductal papilloma. D. Left axillary base, non-sentinel lymph node: - Two lymph nodes, no tumor (0/2). Breast Pathologic Parameters. 1. Invasive carcinoma: A. Size: Gross measurement: 6.5cm. B. Composite histologic (modified SBR) grade II. - Architecture: 3. - Nuclear grade: 2. - Mitotic count: 1. C. Associated ductal carcinoma in situ (DCIS): - High nuclear grade, solid type. - Associated with (forming 5% of tumor volume) and extending away (focal to. involved lactiferous ducts and nipple) from index lesion. 2. Excisional biopsy margins: Free of tumor. - DCIS > 1cm from deep (closest) margin. - Invasive carcinoma 5mm from deep (closest) margin. 3. Blood vessel and lymphatic invasion: - Rare microscopic foci worrisome for lymphatic involvement in breast. parenchyma. 4. Axillary lymph nodes: Negative for tumor (0/4). 5. Special studies (see. - Strong expression of ER in 100% of invasive tumor nuclei. - Strong expression of PR in 100% of invasive tumor nuclei. - Her2/neu antigen (FISH): pending on prior biopsy material. 6. pTNM: pT3, NO(sn), MX. Clinical History: The patient is a. .year-old female with palpable left breast mass. Biopsy at. outside hospital showed invasive ductal carcinoma, ER/PR positive, HER-2. negative. Breast MRI on. ;howed left inferior irregular margin. with irregular mass and heterogenous enhancement at 6 o' clock position. Multiple contiguous satellite lesions are present predominantly extending. anterior from the mass. Overall dimensions are 6.4 x 6.1 x 4.1 cm. The right. breast was normal. Bilateral axillae were normal. Specimens Received: A: Left axillary sentinel node. B: Left axillary sentinel node. C: Left breast. D: Non-Sentinel node base of axilla. Gross Description: The specimen is received in four containers each labeled with the patient' S. name and medical record number. A. Container A is further identified as, 3left axillary sentinel node4. Received fresh is a 2.5 X 1.5 x 1.0 cm apparent lymph node with blue ink. The. specimen is bisected and entirely submitted for frozen section with the. diagnosis of 3no evidence of tumor4 per. The frozen remnant is. entirely submitted in cassette A1FS. B. Container B is further identified as, 3left axillary sentinel node4. Received fresh is a 2.0 x 1.5 x 1.0 cm apparent lymph node with blue ink. The. specimen is bisected and entirely submitted for frozen section with a diagnosis. of 3no evidence of tumor4 per. The remnant of the frozen section is. entirely submitted in cassette B1FS. C. Container C is further identified as, 3left breast4. Received fresh and. placed in formalin is a specimen mastectomy weighing 1100 grams measuring 23.8. cm from medial to lateral, 17.4 cm from superior to inferior, 6.0 cm from. anterior to posterior. The specimen is oriented with two short sutures. designated as superior and two long sutures designated as lateral. The breast. is overlaid with 14.5 x 10.5 cm adipose and skin. Eccentricallylocated is a. 5.8 x 5.2 cm areola with a nipple with a diameter of 1.5 cm. The nipple areolar. complex displays no evidence of ulceration or retraction. The deep fascia is. inked black and the specimen is sectioned from medial to lateral into ten. slices, with the medial slice designated as slice 1. The nipple is located in. slice 4 and slice 5. A 6.5 x 4.9 x 3.3 cm mass is located in slice 4 through. slice 7. The mass is white and firm and inferior to the nipple. The margin of. the mass is irregular especially at the anterior aspect. A satellite lesion is. identified superior and anterior to the index mass located in slice 5 measuring. 1.5 x 1.1 x 1.1 cm and is 0.4 cm from the nearest skin. The mass is 1.0 cm from. the closest inked margin on slice 5. A 2.0 x 2.0 x 1.5 cm black discolored area. is identified in slice 3 and 4 and another 4.0 x 3.8 x 2.0 cm blue discolored. area is identified on slice 5 and 6. The remainder of the breast consists. approximately 17% of adipose tissue and 30% of breast duct parenchyma. Additional masses or nodules are not grossly identified. Representative. sections are submitted as follows: C1: nipple. C2-C3: areola. C4-C7: full section of the tumor on slice 5 with cassette 4 showing. the closest deep margin and cassette. 6 showing the satellite lesion and the closest skin. C8: section from slice 5 showing satellite lesion and the closest skin. C9: representative sections from the tumor on slice 6. C10: inner upper quadrant slice 3. C11: inner upper quadrant slice 4. C12: inner lower quadrant slice 3. C13: inner lower quadrant slice 2. C14: outer upper quadrant slice 5. C15: outer upper quadrant slice 8. C16: outer lower quadrant slice 8. D. Container D is further identified, as 3non-sentinel node base of axilla. left4. Received fresh and placed in formalin are two apparent lymph nodes. measuring 1.8 x 1.0 x 0.6 cm and 1.2 x 0.7 x 0.5 cm. The specimen is entirely. submitted in cassettes D1-D2 with one lymph node in each cassette bisected. Intraoperative Consult Diagnosis: A1FS. Left axillary sentinel node: No evidence of tumor. B1FS. Left axillary sentinel node: No evidence of tumor.",BRCA,0,"The report states that there is no tumor found in the sentinel lymph nodes (0/1) and non-sentinel lymph nodes (0/2) that were examined. Therefore, the N stage is N0, which indicates no regional lymph node metastasis.",N0,6.0
837,TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF,1,"Breast, left, modified radical mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III),. forming a mass (2.3 x 2.1 x 1.7 cm) located in the superior/central aspect of the breast [AJCC pT2]. Ductal carcinoma in situ, intermediate nuclear grade, comprises approximately 5-25% of the tumor. volume. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma shows. nonproliferative fibrocystic changes. The tumor does not involve the nipple, overlying skin, or. underlying chest wall. All surgical resection margins, after re-excision of the anterior/superior margin,. are negative for tumor (minimum tumor free margin, 0.7 cm, anterior/superior margin). The deep margin. is negative for tumor (free by 0.8 cm). Multiple (22) left mid/low axillary lymph nodes are negative for. metastatic carcinoma. Lymph nodes, left high axillary, excision: Multiple (3) left high axillary lymph nodes are negative for. tumor. Lymph node, left axillary sentinel, excision: A single left axillary sentinel lymph node is positive for. metastatic adenocarcinoma with one metastasis measuring 2.5 x 2.5 x 1.3 cm [AJCC pN1]. Extranodal. extension is not present. Blue dye is not identified.",BRCA,1,"The report states that a single left axillary sentinel lymph node is positive for metastatic adenocarcinoma with one metastasis measuring 2.5 x 2.5 x 1.3 cm [AJCC pN1]. This indicates that the patient has metastasis in 1-3 axillary lymph nodes, which corresponds to N1 stage.",N1,7.0
558,TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0,0,"1. y. /F. Speciment. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY COMPLETR/SIMPLE w/ SENTINED NODE BX. TISSUE REMOVED. A. LT SIMPLE MASTECTOMY. B. LT AXILLA SENTINEL NODE #1. C. LT UPPER INNER CORE BX. D. LT BREAST SUPERFICIAL MARGIN. E. LT AXILLA SENTINEL NODE #2. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT SIMPLE MASTECTOMY. STITCH 12 O' CLOCK, IS A LEFT SIMPLE MASTECTOMY SPECIMEN MEASURING 16 x 16. x 3.5 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 7.5 x 4.2 CM SKIN ELLIPSE. BLUE DYE IS NOTED IN THE SUPERIOR 12 O'CLOCK AREA OF THE BREAST. THE. SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH BLACK. AN M. CLIP IS IDENTIFIED IN THE UPPER INNER QUADRANT MEDIAL ASPECT, ASSOCIATED. WITH A PINK-TAN NODULE AT THE SUPERFICIAL MARGIN MEASURING 0.9 x 0.5 x. 1.2 CM. THIS IS 1.3 CM FROM THE DEEP MARGIN, 1 CM FROM THIS IS A 0.3 CM. FIRM GRAY-TAN AREA WHICH IS 1 CM FROM THE SUPERFICIAL MARGIN AND 1.1 CM. FROM THE DEEP MARGIN GROSSLY. IN THE 11 O'CLOCK AREA THERE IS AN. ELONGATED IRREGULAR PINK-TAN FIRM AREA WHICH ALSO EXTENDS GROSSLY TO THE. SUPERFICIAL MARGIN. THIS MEASURES 3.5 x 0.9 AND IS 1.5 CM IN GREATEST. DIMENSION. THIS LESION IS GROSSLY 3 CM FROM THE FIRST DESCRIBED LESION. THIS LESION GROSSLY EXTENDS TOWARDS THE SUPERFICIAL MARGIN AND IS 1.2 CM. FROM THE DEEP MARGIN. THE BREAST TISSUE ITSELF HAS AN OVERALL INDURATED. QUALITY TO PALPATION WITH A DIFFUSE YELLOW-GRAY APPEARANCE. THE INFERIOR. AND LATERAL ASPECTS DEMONSTRATE A MORE FATTY APPEARANCE. ALSO IN THE. AREA OF THE UPPER INNER QUADRANT, THE PARENCHYMA HAS MULTIPLE SMALL. PALPABLE LESIONS. THIS IS IN THE AREA OF THE BLUE DYE. IT IS SECTIONED. TO DEMONSTRATE THIS WHICH IS SLIGHTLY INFERIOR AND TOWARD THE NIPPLE FROM. THE SECOND DESCRIBED LESION SUBMITTED IN A10 (MIRROR IMAGE TO PROTOCOL). RANDOM TISSUE IS ALSO TAKEN FROM THE 9 O'CLOCK AREA WHICH HAS THIS. DIFFUSE INDURATED QUALITY. THE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE AND SKIN (MIRROR IMAGE TO PROTOCOL), A2--10 O'CLOCK PERIPHERAL. LESION TO INCLUDE SUPERFICIAL AND DEEP MARGINS (MIRROR IMAGE TO. PROTOCOL), A3--10 O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A4--MMALL. 0.3 CM NODULE WITHIN TISSUE (MIRROR IMAGE TO PROTOCOL), 15--SECTION OF 11. O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A6 THROUGH A8--FOR. CROSS-SECTION OF 11 ''CLOCK LESION TO INCLUDE THE MOST SUPERIOR AND. SUPERFICIAL, DEEP AND SUPERFICIAL INFERIOR ASPECT OF LESIONS TO INCLUDE. SUPERFICIAL MARGIN RESPECTIVELY, A9--11 O'CLOCK LESION (MIRROR IMAGE TO. Speciment. Spec Type: SURGICAL p. GROSS DESCRIPTION. PROTOCOL), A10--TISSUE UPPER OUTER QUADRANT, A11--TISSUE 9 0'CLOCK A. REGION, A12-UPPER OUTER QUADRANT 4 CM FROM THE 11 O'CLOCK LESION (MIRROR. IMAGE TO PROTOCOL). 13--LOWER OUTER QUADRANT 8 CM FROM THE LESION. (MIRROR IMAGE TO PROTOCOL), A14--LOWER INNER QUADRANT. PART B RECEIVED FRESH LABELED. LEFT AXILLA FIRST SENTINEL. NODE HOT AND BLUE, IS A AN OVOID PORTION OF PINK-TAN SOFT TISSUE. MEASURING 2.5 x 1.3 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY. UNREMARKABLE LYMPH NODE WITHOUT OBVIOUS BLUE COLORATION. ONE HALF IS. SUBMITTED LABELED B. THE REMAINDER IS SUBMITTED PER PROTOCOL. PART C RECEIVED LABELED. LEFT UPPER INNER CORE BIOPSY. SITE, IS AN UNORIENTED ELLIPTICAL PORTION OF BROWN SKIN AND UNDERLYING. INDURATED FATTY TISSUE. THE SKIN ELLIPSE IS 1.4 x 0.5 CM. THE. UNDERLYING TISSUE MEASURES 2.1 x 0.9 x 1.8 CM. ON THE SKIN SURFACE THERE. IS A RAISED CENTRAL LESION 0.5 CM DIAMETER. THE MARGIN IS MARKED WITH. INK. THE SPECIMEN IS SECTIONED ACROSS THE NARROW MARGIN OF THE SKIN AND. THE 2 EXTREME ENDS (ELLIPTICAL END OF THE SKIN ARE SUBMITTED IN C1 WITH. THE CENTRAL TISSUE IN C2). PART D RECEIVED LABELED. LEFT BREAST SUPERFICIAL MARGIN IS. AN IRREGULAR ELONGATED FRAGMENT OF YELLOW-PINK FATTY TISSUE MEASURING 8.5. x 2.1 x 0.5 CM IN GREATEST DIMENSION. THE SPECIMEN IS NOT OTHERNISE. ORIENTED. ONE SIDE HAS A DULL APPEARANCE AND IS MARKED WITH BLUE INK. THE OPPOSITE SIDE IS MARKED YELLOW. THIS IS SECTIONED AND ENTIRELY. SUBMITTED LABELED D1 THROUGH D5. PART E RECEIVED FRESH LABELED. LEFT AXILLA SECOND SENTINEL. NODE HOT, IS AN OVOID PORTION OF YELLOW-PINK FATTY TISSUE MEASURING 2.9. x. 1.7 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY UNREMARKABLE LYMPH. NODE QUBMITTED ENTIRELY LABELED E. PATH PROCEDURES. PROCEDURES: 88307/5, IMMUNOPEROXIDAS/2, A BLK/14, BBX x6, C BLK/2, D BLK/5, EBX X6. FINAL DIAGNOSTS. PART. A LEFT SIMPLE MASTECTOMY MULTICENTRIC IN SITU AND INFILTRATING. DUCT CARCINOMA WITH AT LEAST FOUR SEPARATE FOCI OF TUMOR PRESENT. THE 10. O'CLOCK NODULE SHOWED IN SITU AND MODERATELY DIFFERENTIATED INFILTRATING. DUCT CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX,. ASSOCIATED WITH A PREVIOUS BIOPSY SITE WITH APPROXIMATELY 1.0 CM OF IN. SITU AND 1.2 CM OF INVASIVE CARCINOMA. THIS LESION EXTENDED TO WITHIN. LESS THAN 1 MM OF THE SUPERFICIAL MARGIN. IN THE 11 O'CLOCK POSITION,. APPROXIMATELY 1.9 CM OF INVASIVE CARCINOMA WAS PRESENT ASSOCIATED WITH. 2.2 CM OF DUCT CARCINOMA IN SITU SHOWING SIMILAR NUCLEAR GRADE AND. HISTOMORPHOLOGY. THIS LESION WAS 5 MM FROM THE DEEP MARGIN AND WAS. specimens. Spec Type: SURGICAL P. FINAL DIAGNOSIS. ASSOCIATED WITH A PREVIOUS BIOPSY SITE. THE PREVIOUS BIOPSY SITE. EXTENDED TO THE SUPERFICIAL MARGIN. A SECTION OF BREAST TISSUE FROM THE. UPPER OUTER QUADRANT OF THE BREAST SHOWED APPROXIMATELY 1.1 CM OF DUCT. CARCINOMA IN SITU AND 0.5 CM OF INVASIVE CARCINOMA WITH SIMILAR. HISTOMORPHOLOGY. AN ADDITIONAL NODULE FROM THE UPPER INNER QUADRANT OF. THE BREAST SHOWED CHANGES OF A PREVIOUS BIOPSY SITE BUT NO RESIDUAL TUMOR. PARTS B AND E LEFT AXILLARY SENTINEL LYMPH NODES NUMBERS 1 AND. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING. PART C LEFT UPPER INNER CORE BIOPSY SITE, REEXCISION: SKIN AND BREAST. TISSUE CONTAINING A PREVIOUS NEEDLE CORE BIOPSY SITE ASSOCIATED WITH. REACTIVE FIBROSIS AND INFLAMMATION. NO RESIDUAL TUMOR IDENTIFIED. THE. PREVIOUS BIOPSY CHANGES EXTEND INTO THE DERMIS. UIQ s-exe - tumor. PART D LEFT BREAST SUPERFICIAL MARGIN, REEXCISION: ADIPOSE TISSUE WITH. NO EVIDENCE OF MALIGNANCY. CODE. 1. (prelim.). (signature on file).",BRCA,0,"The pathology report does not mention any metastasis to the axillary lymph nodes. The reexcision of left breast superficial margin (part D) and the left upper inner core biopsy site (part C) did not reveal any metastatic disease. The sentinel lymph nodes (parts B and E) also had no evidence of metastatic disease, as confirmed by negative cytokeratin immunohistochemical staining.",N0,8.0
685,TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0,1,"Diagnosis: Invasive lobular breast carcinoma (maximum diameter 2.5 cm, malignancy grade II), with. excision extending into the healthy tissue. Tumor classification (also taking into account xxxxxxxx): pT2 (maximum diameter 2.5 cm),. pNO sn (0/1), MX, R0, G2 (L0, V0).",BRCA,0,"The report specifies pNO sn (0/1), which indicates that there is no metastasis in the regional lymph nodes (N0) based on the information provided in the rules.",N0,9.0
1069,TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1,1,"PATIENT HISTORY: SPECIMENS TAKEN BY PATH DATE of LMP: (NOT LISTED ON REQUISITION). DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: RIGHT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SENTINEL LYMPH NODE, R SEGMENTAL MASTECTOMY. CLINICAL HISTORY: SPECIMENS TAKEN BY PATH. MATERIAL SUBMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE. B) RIGHT BREAST BICPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. Long-lat,med-med, sht-superior. INTRAOPERATIVE CONSULTATION: R SENTINEL LYMPH NODE #1: One lymph node, 0.8 by 0.6 by 0.5 cm. Touch Prep. Diagnosis: Negative. ADDENDA: Addendum. FISH analysis using DNA probe for Her-2/neu gene showed that, the ratio of Her-2/neu signals to chromosome 17. centromere signais is 0.94 (> 2.0 ratio is considered amplified). Therefore, Her-2/neu gene is not amplified. Bv Pathologi. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. Addendum. MATERIAL SUBMITTED: BLOCK ""B3"" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONT RECEPTORS AND HER-2/NEU PERFORMED ON RIGHT BREAST TISSUE. ESTROGEN RECEPTOR (0- 40%; 1+ 40%; 2+ 10%; 3+ 10%) HSCORE OF 90. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONS RECEPTOR (0- 70%; 1+ 10%; 2+ 10%; 3+ 10%) HSCORE OF 60. PROGESTERONI RECEPTOR IS INTERPRETED AS. POSITIVE. HER-2/NEU-DAKO HERCEPTEST. A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF THE. TUMOR CELLS. HER-2/NEU IS INTERPRETED AS POSITIVE (SCORE 2+). HSCORE: <= 15 NEGATIVE. >15<=30 BORDERLINE. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT SENTINEL LYMPH NODE #1: - MICROMIETASTATIC DUCTAL CARCINOMA OF THE BREAST (SEE NOTE). B) RIGHT SEGMENTAL MASTECTOMY: INFILTRATING MODERATELY DIFFERENTIATED DUCTAL CARCINOMA) NOTTINGHAM SCORE 6/9 (TUBULES=3, NUCLEI=2,. MITOSIS-1) SIZE 2.5 BY 2.0 BY 1.5 CX. - DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE, SOLID AND CRIBRIFORK) NUCLEAR GRADK 1, CONSTITUTES 5% or. ENTIRE. TUMOR MASS. - SEVERAL MICROSCOPIC FOCI OF INFILTRATING ADENOCARCINOMA, UP TO 0.5 CM, IN THE REMAINING BREAST TISSUE. #9, #12). - LATERAL AND INFERIOR SURGICAL MARGINS POSITIVE FOR INVASIVE TUMOR. - INTRADUCTAL PAPILLOMA AND PROLIFERATIVE FIBROCYSTIC CHANGES IN THE REMAINING BREAST TISSUE. FOCAL NECROSIS AND GRANULATION TISSUL, STATUS-POST CORE BIOPSY or BREAST (CROSS REFER. NOTE: Minute clusters of metastatic ductal carcinoma was found in serial section ""Al"", but it ie best. visualized with the immunoperoxidase stain AB1/AR3 in serial section A2. The immunostain was repeated and. the presence of metastatic neoplastic cells in the lymph node section ""Al"" was confirmed by. immunostaining (""A26A3""). The later serial sections of the lymph nodes are negative. The touch prep of. the. sentinel node was re- reviewed and no malignant cells are identified ER/PR immunoperoxidase assay and Her-. 2/NEU testing will be performed on block ""B3"". The special stains and/or immunoperoxidase tests used in thi ~ase hatra bean and their performance. characterietics determined by the Department of Pathology at. They have not been cleared or approved by the U.S. Food and Drug Administration.",BRCA,1,The report mentions 'Minute clusters of metastatic ductal carcinoma was found in serial section 'Al'' which indicates metastasis in 1-3 axillary lymph nodes (N1 stage) according to the rules provided.,N1,10.0
1469,TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740,1,"FINAL PATHOLOGIC DIAGNOSIS. Left simple mastectomy and sentinal node biopsy: A. Sentinal lymph node #1: -One lymph node, no tumor (0/1). B. Sentinel lymph node #2: -One lymph node, no tumor (0/1). C. Left breast (mastectomy): -Intraductal apocrine ductal carcinoma with lobular cancerization and rare. foci of. invasion (largest focus 3mm), associated with large area of recent. hemorrhage (5 cm),. see below. -Separate mass of intraductal and infiltrating ductal carcinoma (2.5 cm). inferior to hemorrhagic region. -Small intraductal papilloma, sclerosing adenosis and radial scar lesion. -Calcifications in vessel walls. -Nipple, no tumor. Breast Pathologic Parameters. 1. Intraductal carcinoma: A. Size: Gross measurement: 5 cm. B. Type: Comedo, solid, apocrine. C. Nuclear grade: High. (Modified Lagios Grading Scheme). D. Associated features: Necrosis, Cancerization of lobules. 2. Invasive carcinoma: A. Size: Gross measurement: 1.0 x 1.0 x 0.6 cm. B. Composite histologic (modified SBR) grade: III. - Architecture: 3. - Nuclear grade: 3. - Mitotic count: 2. C. Associated ductal carcinoma in situ (DCIS): - Within main mass (forming 50 % of tumor volume). - Extending away from main mass. 3. Excisional biopsy margins: Free of tumor. Margins greater than 2mm away. 4. Blood vessel and lymphatic invasion: Absent. 5. Axillary lymph nodes: Negative for tumor (0/2). 6. Special studies. -No expression of ER in invasive tumor nuclei. -No expression of PR in invasive tumor nuclei. -Her2/neu antigen (FISH): Pending. 7. pTNM: pT2,N0,MX. Clinical History: This is a. year-old female with history of a right papilloma. A screening. mammogram in. showed suspicious densities with calcifications in. the left outer quadrant. By exam showed a 1.5 cm quasi suspicious mass at. 4-5:00, 3 cm outside the areola margin on the left breast. , she had a. FNA of the left breast showing carcinoma. On. 1 breast MRI on the. left showed an outer quadrant 4.7 x 3.2 x 3.3 cm enhanced mass with three. additional suspicious foci: one anterior and superior to the index mass, one. adjacent to the nipple, and one suspicious focus at 12 o'clock. The patient. undergoes a left breast sentinel node biopsy and simple mastectomy. Specimens Received: A: Sentinel Node #1. B: Sentinel Node #2. C: Left Breast Mastectomy with Sentinel Node Biopsies. Gross Description: The specimens are received in three containers each labeled with the patient' S. name and medical record number. A. Container A is further designated 31. sentinel node #14. Received for. frozen section diagnosis is a 1.8 x 1.2 x 0.5 cm rubbery portion of yellow,. lobulated tissue with blue discoloration. It is read as 3one lymph node,. negative for carcinoma4 by. The specimen is entirely submitted as. A1FS. B. Container B is further designated 32. sentinel node #24. Received for. frozen section diagnosis is a 1.5 x 0.8 x 0.8 cm portion of pink-tan rubbery. tissue consistent with a lymph node. It is bisected and read as 3one lymph. node, negative for carcinoma4 by. The specimen is entirely submitted. in cassette BIFS in a mesh bag. C. Container C is further designated 33. left breast mastectomy with sentinel. node biopsies4. Received fresh and placed in formalin is a 975 gm, 39 X 18 x 6. cm mastectomy specimen with an ellipse of white-tan skin with blue discoloration. (27 X 11.2 cm), areola (4.7 x 4.5 cm), and nipple (1.2 x 1.0 x0.4 cm). The. specimen is oriented as follows: short suture superior, long suture lateral. The deep margin is inked black and the specimen is serially sectioned into 13. slices from lateral (slice #1) to medial revealing a 5 x 5.5 x 4 cm ecchymotic. area in the lower lateral quadrant located in slices #4-7. There is a. well-circumscribed, firm, white mass measuring 2.5 x 1.7 x 1.5 cm in slice #5,. 5.5 cm from the deep margin. It is located inferior to the ecchymotic region. At 2-3 o'clock adjacent to the firm mass is an ill-defined, gritty, indurated. area primarily in slices #7 and #8. It extends superomedially with a span of 5.0. X 3.5 x 2.0 cm and is located 2.5 cm from the deep margin. Note: slices #7 and. #8 contain the nipple and areola region. Cassette SummaryCl: nipple. C2-C4: areola, serially sectioned. C5: section of the main mass in slice #5 with respect to closest distant. from deep margin. C6-C7: one representative section immediately superior and anterior to the. main lesion from slice #5. C8: section of hematoma from slice #5 anterior and medial to the main lesion. C9: section of hematoma from slice #6, directly medial to the main lesion. C10: section 2 cm superior, anterior, and medial to the main lesion from. slice #7. C11: representative sections from slice #8, representing ill-defined,. gritty, firm tissue. C12-C13: section from slice #7 also representing ill-defined, gritty, firm. tissue. C14: another section from slice #7 immediately inferior to the section. C12-C13. C15-C16: section from 12 o'clock on section #8. C17-C18: sections from slice #9. C19: another representative section from section #9. C20-C21: lateral upper quadrant from slices #3-4, respectively. C22-C23: lateral lower quadrant from slices #2 and #3, respectively. C24-C25: upper medial quadrant from slice #11 and #12, respectively C26-C27: medial lower quadrant from slices #11 and #12, respectively. Intraoperative Consult Diagnosis: A1FS. Sentinel node #1: One lymph node, negative for carcinoma. B1FS. Sentinel node #2: One lymph node, negative for carcinoma.",BRCA,0,"The report states that there were two sentinel lymph nodes examined and both were negative for tumor (0/2). This indicates no regional lymph node metastasis, which corresponds to N0 stage.",N0,10.0
1106,TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181,0,"""/a 2/10. page 1 / 1. copy No. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Results of immunohistochemical examination: Estrogen receptors found in 10-75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of. neoplastic cell nuclei. HER2 protein stained with HercepTest™ by DAKO. Negative reaction in invasive. cancerous cells I Score = 1+. Macroscopic description: Right breast, sized 16.6 x 12.4 x 4.8 cm, removed along with axillary tissues sized 8 x 6 x 2 cm and a skin flap. of 10,7 x 8,4 cm. Weight 513 g. Tumour sized 1,5 x 1,9 x 1,0 cm in the upper outer quadrant, placed 3.3 cm from the upper edge, 0.1 cm. from the base and 0.8 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 (3 + 3 +3: 52 mitoses/ 10 HPF, visual area diameter: 0.55 m). Tumour of. ""basal - like carcinoma"" morphology ? Ma mi 11 a sine laesionibus. Glandular tissue showing lesions of the type mastopathia fibrosa et cystica. Additional parenchyma atrophy. AXILLARY LYMPH NODES. Lymphonodulitis chronica et sinus histiocytosis lymphonodorum (No VI). Examination result: Carcinoma ductale invasivum mammae dextrae. (NHG3, pTIc, pNO). Tumour of ""basal - like carcinoma"" morphology.",BRCA,0,"The report explicitly states 'pNO', which indicates no regional lymph node metastasis. This is consistent with the rules that mention the absence of tumor in the sentinel lymph node excision indicates no regional lymph node metastasis (N0).",N0,11.0
981,TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21,1,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT AXILLARY, SENTINEL NODE NUMBER 1, SENTINEL NODE BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). PART 2: LYMPH NODE, RIGHT AXILLARY, SENTINEL NODE NUMBER 2, SENTINEL NODE BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). PART 3: LYMPH NODE, RIGHT AXILLARY, NONSENTINEL, LYMPH NODE BIOPSY -. TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). PART 4: LYMPH NODE, RIGHT AXILLARY, SENTINEL NODE NUMBER 3, SENTINEL NODE BIOPSY -. ONE LYMPH NODE POSITIVE FOR MICROMETASTATIC CARCINOMA (1/1). PART 5: BREAST. RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA. B. NOTTINGHAM SCORE 4/9, GRADE 1 (TUBULES 2, NUCLEI 1, MITOSES 1). C. NEOPLASM MEASURES 2.8 CM IN MAXIMUM DIMENSION (see comment). D. NO LYMPHOVASCULAR INVASION IDENTIFIED. E. NEOPLASM EXTENDS FOCALLY TO POSTERIOR MARGIN OF RESECTION IN THE INFERIOR ASPECT. (BLOCK 5J), ALL OTHER MARGINS OF RESECTION FREE OF NEOPLASM. F. ER POSITIVE, PR NEGATIVE, HER-2/NEU NEGATIVE PER PREVIOUS REPORT. G. PATHOLOGIC STAGE: pT2, pN1, pMX. H. DUCTAL CARCINOMA IN SITU, CRIBRIFORM AND MICROPAPILLARY TYPES, NUCLEAR GRADE 1 WITH. ASSOCIATED MICROCALCIFICATIONS AND FOCAL COMEDONECROSIS. I. IN SITU COMPONENT IS ADMIXED WITH INVASIVE COMPONENT AND IS IDENTIFIED IN EIGHT BLOCKS. (THREE CONSECUTIVE SLICES MEASURING APPROXIMATELY 1.2 CM). J. MARGINS OF RESECTION FREE OF IN SITU COMPONENT, CLOSEST INFERIOR AT 0.3 CM. K. ATYPICAL DUCTAL HYPERPLASIA. L. FAT NECROSIS AND REPARATIVE CHANGES ASSOCIATED WITH PREVIOUS BIOPSY. M. FIBROCYSTIC CHANGES WITH SCLEROSING ADENOSIS, DUCTAL EPITHELIAL HYPERPLASIA,. FIBROADENOMATOUS NODULE AND EPITHELIUM ASSOCIATED CALCIFICATIONS. PART 6: LYMPH NODES, RIGHT AXILLARY, AXILLARY DISSECTION -. NINETEEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/19). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: PROCEDURE: Right. Segmental. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2.8 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 1. Tubule formation: 2. Mitotic activity score: 1. Total Nottingham score: 4. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 1. DERMAL LYMPHATIC INVASION: CALCIFICATION: Not applicable. Yes, benign zones. TUMOR TYPE, IN SITU: Yes, malignant zones. Cribriform. Micropapillary. DCIS admixed with invasive carcinoma. SURGICAL MARGINS INVOLVED BY INVASIVE Percent of COMPONENT: tumor occupied by in situ component: 5 %. Yes, focal. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: Distance of in situ disease to closest margin: 3 mm. 3. LYMPH NODES EXAMINED: 24. METHOD(S) OF LYMPH NODE EXAMINATION: SENTINEL NODE METASTASIS: H/E stain, Keratin stain. ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 25.0 mm. NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: zero or 1+.",BRCA,1,"The report mentions metastasis in 1-3 axillary lymph nodes (part 1, 2, and 4). Specifically, 3 out of 24 lymph nodes were positive for metastatic carcinoma. This information indicates a pN1 stage according to the AJCC staging system.",N1,12.0
1301,TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE,1,"Laterality:Left, lower inner quadrant. Path Report: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Lower inner quadrant. Tumor size: 2.7 x 0 x 3.2 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Skin. Lymph nodes: 6/10 positive for metastasis (Axillary 6/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",BRCA,2,"The report states that 6 out of 10 lymph nodes are positive for metastasis (Axillary 6/10). This falls under the 'N2' category, which indicates metastasis in 4-9 axillary lymph nodes.",N2,13.0
1070,TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28,1,"Procedure Date: Procedure Physician: Attending Physician/Copies To: RATIENT HISTORY: DATE of LMP. DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT MOD RAD MAST. CLINICAL HISTORY: MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: Left Breast - measures 30.0 x 13.5 x 4.5 cm with attached skin ellipse, 19.0 x 9.2 x 0.3 cm. Specimen inked. and sectioned with a 4.5 x 4.0 x 4.0 cm tumor, 0.5 cm from posterior margin. FINAL DIAGNOSIS: FINAL DIAGNOSIS: LEFT BREAST, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, 4.5 BY 4.0 BY 4.0 CM, GRADE 2. NOTTINGHAM SCORK 6/9 (TUBULES 2/3, NUCLEAR ATYPIA 2/3, MITOSIS 2/3). - TUMOR IS LESS THAN 1 CM FROM THE DEEP MARGIN. - ALL OTHER MARGINS ARE FREE OF TUMOR. - SKIN AND NIPPLE, FREE OF TUMOR. - FOCAL ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA AND NODULES. - TWELVE (12) LYMPH NODES, NEGATIVE FOR TUMOR. - MICROCALCIEICATION ASSOCIATED WITH TUMOR. - NO LNMPHOVASCULAR INFILTRATION SEKN. ER/PR AND PER-2/NEU RESULTS. IMMUNOPEROKIDASE IDENTITICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE A3. DISTINCT. INTRANUCLEAR STAINING IS IDENTIFIED FOR BOTH ESTROGEN RECEPTOR (70%) AND PROGESTERONI RECEPTOR (90%). THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. c-erb82 (HER-2/NEU) IMMUNOSTAININC IS CARRIED OUT ON BLOCK A3 (BREAST CANCER;) USING A 1:300 DILUTION OF. DAKO'S. POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erbB2) WITHOUT ANTIGEN. RETRIEVAL. DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED IN LESS THAN 10% OF TUMOR CELLS. THEREFORE,. erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 0). NOTE: The special stains and/or immunoperoxidase tests used in this case have been develoned and their. performance characteristics determined by the Department of Pathology at. They have not been cleared or approved by the U.S. Food and Drug Administration.",BRCA,0,"The report mentions that 12 lymph nodes were negative for tumor (pN0) and there is no explicit mention of the number of involved lymph nodes. Therefore, the N stage is N0.",N0,14.0
640,TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.5 cm) with focally. marked intraductal patterns of spread. Concluding tumor classification: NOS, G III, pT2N1aLOV0RX. IGA-A8-A0S4-01A-PR.",BRCA,1,The report explicitly mentions that the tumor has metastasized to 1-3 axillary lymph nodes (pT2N1aLOV0RX). This corresponds to the N1 stage according to the rules.,N1,15.0
1104,TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C,1,"FINAL DIAGNOSIS: PART 1: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISION -. ONE LYMPH NODE,. POSITIVE FOR. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISION -. METASTATIC CARCINOMA (1/1). Carcinorna, soluular initiating 0852013. ONE LYMPH NODE, POSITIVE FOR METASTATIC CARCINOMA (1/1). PART SENTINEL LYMPH NODE #3, EXCISION. 3: ONE LEFT LYMPH AXILLA, NODE, POSITIVE FOR METASTATIC CARCINOMA - (1/1). Sute L. PART 4: LEFT NIPPLE, POSTERIOR, BIOPSY -. A. ATYPICAL LOBULAR HYPERPLASIA. B. NO INVASIVE CARCINOMA PRESENT. PART 5: LEFT BREAST, NIPPLE SPARING MASTECTOMY -. A. INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, 2.5 x 1.5 x 1.2 CM ASSOCIATED WITH. MICROCALCIFICATIONS. B. NOTTINGHAM GRADE 2 (TUBULES 3, NUCLEAR PLEOMORPHISM 2, MITOTIC ACTIVITY 1; TOTAL SCORE. 6/9). C. LOBULAR CARCINOMA IN-SITU (LCIS) WITH PAGETOID EXTENSION INTO DUCTS AND ASSOCIATED. MICROCALCIFICATIONS. D. NO LYMPHOVASCULAR SPACE INVASION IDENTIFIED. E. SURGICAL MARGINS NEGATIVE. F. INVASIVE TUMOR IS 0.3 CM FROM ANTERIOR MARGIN. G. INVASIVE TUMOR IS LOCATED AT JUNCTION BETWEEN UPPER/OUTER AND UPPER/INNER QUADRANTS. H. SUBAREOLAR TISSUE INVOLVED BY LCIS, BUT NEGATIVE FOR INVASIVE CARCINOMA. I. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSIES. J. FIBROCYSTIC CHANGES WITH FOCAL APOCRINE METAPLASIA. K. FIBROADENOMATOUS CHANGES. L. UNREMARKABLE SKELETAL MUSCLE. M. BENIGN EPITHELIAL CALCIFICATIONS. N. THE INVASIVE TUMOR CELLS WERE REPORTED TO BE POSITIVE FOR ESTROGEN RECEPTORS, POSITIVE. FOR PROGESTERONE RECEPTORS, AND NEGATIVE FOR HER-2, WITH A KI-67 PROLIFERATION INDEX OF. 1%, AS PER PREVIOUS PATHOLOGY REPORT. CASE SYNOPSIS: SYNOPTIC . PRIMARY INVASIVE CARCINOMA OF BREAST. LATERA. JTY: Left. PROCEDURE: Simple mastectomy. Upper outer quadrant. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 25 mm. MULTICENTRICITY/MULTIFOCALTY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 3 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 3. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 7 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: ALH, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 1+.",BRCA,1,"The report explicitly mentions metastatic carcinoma in 3 sentinel lymph nodes (part 1, 2, and 3). This indicates N1 stage, as N1 includes metastasis in 1-3 axillary lymph nodes.",N1,16.0
619,TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma with focal angioinvasion. (tumor diameter 2.2 cm). Concluding tumor classification: NOS, G III, pT2N1aL1V0R0.",BRCA,1,"The report explicitly mentions that the tumor is pT2 (tumor size > 2 cm and $\leq$ 5 cm) and pN1a (metastasis in 1-3 axillary lymph nodes). Therefore, the N stage is N1.",N1,17.0
1210,TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77,1,"SPECIMENS: A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. B. ADDITIONAL LEFT AXILLARY CONTENTS. SPECIMEN(S): A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. B. ADDITIONAL LEFT AXILLARY CONTENTS. GROSS DESCRIPTION: A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. Received fresh labeled with the patient's identification and ""left breast and axillary contents levels one and two. (suture in axillary tail)"" is an oriented 1794 g, 31 x 22 x 4.5 cm mastectomy with 27 x 16 skin ellipse and 1.1-cm flat. nipple. Skin has 4 brown macules ranging from 0.2 to 0.4 cm. In code: Anterior/superior-blue, anterior/inferior-. orange, posterior-black Specimen is serially sectioned into 11 slices from medial to lateral with nipple in slice7. #1- is a 2.5 x 2.5 x 1.7 cm firm tan stellate mass which is located at the 12 o'clock position, 4.2 cm from the deep. revealing 4 lesions. margin and 2 cm from the anterior margin (slices 6-7). #2- is a 1.3 x 1.1 x 1 cm firm tan stellate mass which is. located 0.3 cm medial to lesion #1, 5 cm from the deep margin and 1.3 cm from the anterior margin at roughly the 9. o'clock position (slice 5). #3- is a 2.5 x 2.2 x 1.5 cm firm tan stellate mass located 0.4 cm medial to lesion #2, 4 cm. from the deep margin and 1.5 cm from the anterior margin at roughly the 9 o'clock position (slice 4). #4- is a 1 x 1. x. 0.6 cm firm granular mass located 2.5 cm posterior lesion #3, 1.3 cm from the deep margin and 4.5 cm from the. anterior margin (slice 4). Adjacent to the deep margin, in slice 7, is a 0.9 x 0.6 x 0.4 cm firm tan lymph node. Within. the axillary tail are multiple lymph nodes ranging from 0.3 to 3.5 cm. The largest lymph node is nodular and a portion. is procured. Representatively submitted. A1: slice 4, lesion #3. A2: slice 4, tissue connecting lesions #3 and #4. A3: slice 4, lesion #4. A4: slice 4, deep margin lesion 4. A5: slice 5, tissue between lesions 3/4 and #2. A6: slice 5, lesion #2. A7 slice 6, tissue between lesions 2 and 1. A8: slice 6, superior to lesion 1. A9: slice 6, superior part of lesion 1. A10: slice 6, inferior part of lesion 1. A11: slice 6, inferior to lesion 1. A12: slice 6, anterior to lesion 1. A13: slice 7, lateral to lesion 1. A14: slice 3, upper inner quadrant. A15: slice 8, upper outer quadrant. A16: slice 9, lower outer quadrant. A17: slice 3, lower inner quadrant. A18-A19: nipple, perpendicular sections. A20: skin with macules. A21: intramammary lymph node. A22: 5 lymph nodes. A23: 4 lymph nodes. A24-A26: 1 lymph node each. A27-A28: 1 lymph node. A29-A30: 1 lymph node. A31-A36: 1 lymph node. B. ADDITIONAL LEFT AXILLARY CONTENTS. Received fresh labeled with the patient's identification and ""additional left axillary contents"" is a piece of fatty tissue. measuring 6.3 x 4.7 x 0.6 cm. One lymph node is identified. Submitted entirely. B1: 1 lymph node. B2-B4: remainder of soft tissue. DIAGNOSIS: A. BREAST, LEFT, MASTECTOMY WITH AXILLARY NODE DISSECTION: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, SBR GRADE 3 WITH MICROPAPILLARY FEATURES,. LARGEST FOCUS MEASURING 2.5-CM. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH LOBULAR. EXTENSION, CENTRAL NECROSIS AND MICROCALCIFICATIONS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - METASTATIC CARCINOMA TO ONE OF TWELVE AXILLARY LYMPH NODES (1/12), MEASURING 3.5-CM. WITH FOCAL EXTRANODAL EXTENSION. - METASTATIC CARCINOMA TO ONE OF TWO INTRAMAMMARY LYMPH NODES (1/2), MEASURING 0.8-CM. WITH FOCAL EXTRANODAL EXTENSION. - SEE SYNOPTIC REPORT AND SEE NOTE. B. LYMPH NODES, ADDITIONAL LEFT AXILLARY CONTENTS, DISSECTION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). NOTE: Four tumor nodules are grossly identified. Microscopically 3 of them are invasive ductal carcinoma that. have. the same morphology and one is DCIS. The tissues in between these nodules show scattered foci of DCIS. Therefore, these foci may be interconnected through DCIS. Largest confluent invasive tumor measures 2.5-cm. Two intramammary lymph nodes are identified, one is positive for metastatic carcinoma. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.5cm. Tumor Site: Upper inner quadrant. Lower inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Indeterminate. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 2 / 15 Extranodal extension. DCIS present. DCIS Quantity: Estimate 10%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Negative. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 2 N 1c. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist,. Final: Pathologist, (.",BRCA,1,"The report explicitly mentions metastasis in 1 of 12 axillary lymph nodes (1/12), which corresponds to N1 stage. The mention of extranodal extension does not affect the primary N stage.",N1,18.0
1071,TCGA-BH-A1F0.E2EE2397-0F8A-4A71-9B3C-0007F7D00500,0,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT TOTAL MASTECTOMY, LEFT AXILLARY SAMPLING. CLINICAL HISTORY: MATERIAL SUEMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: Left breast with axillary sampling. Mass identified at 1:00 position, 2.0 by 2.0 by 2.0 cm. Second. lesion,. just lateral to first, 1.5 by 1.5 by 1.0 cm. Surgical margins grossly free for both tumors. Axillary tail. containing fatty lymph node with blue coloration (treat as sentinel node). R E V I s E D R E P o R T. IAGNOSIS: Litt BREAST BIOPSY, TOTAL MASTECTONY : TWO (2)  SEPARATE FOCI OF INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED, MULTIFOCAL IN UPPER. OUTER QUADRANT. - SIZK OF THE FOCI ARE 2.0 BY 2.0 BY 2.0 AND 1.5 BY 1.5 BY 1.0 CX. - OOTH TUMORS HAVE IDENTICAL MORPHOLOGY. - NOTTINGHAM SCORE=8 (TUBULES-3, NUCLEAR ATYPIA-3, MITOSIS-2). - ALL SURGICAL MARGINS FREE OF TUMOR. - NIPPLE AND AREOLA WITH NO DIAGNOSTIC CHANGES. - NON-NEOPLASTIC BREAST WITH NO DIAGNOSTIC CHANGES. - ONE (1) LYMPH NODE (SENTINEL) POSITIVE FOR MITASTATIC CARCINOMA (1/9). NOTE: The micrometastasis measures 1.5 mm and was identified both on HES and immunoperoxidase stain. AJCC. stage T1C N1a Mx. The two tumor nodules are located in upper outer quadrant. The tumor adjacent to the. nipple mentioned in the previous report, is part of one of the two tumor nodules  ER/PR immunoperoxidase. assay and Her-2/NEU testing will be performed on block ""A2"". REVISION (GROSS DESCRIPTION). Addendum. MATERIAL SUBMITTED: BLOCK ""A2"" AND ""A4"" FOR ER/PR AND HER-2/NEU. FINAL DIAGNOSIS: ER/PR RESULTS (""A2""). IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTZRONE RECEPTORS IS CARRIED OUT ON SLIDE ""A2"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOCALLY FOR PROGESTERONE RECEPTOR (15%) BUT NOT FOR ESTROGEN. RECEPTOR. THEREFORE, PROGESTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROGEN RECEPTOR AS NEGATIVE. HER-2/NEU RESULTS (""A2""). AS PER THE REQUEST OF DR. c-erb82 (HER-2/NEU) IS CARRIED OUT ON PREVIOUS MAGRE. SURGICAL s. (BREAST CANCER) USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485. (DIRECTED. AGAINST. THE INTRACELLULAR DOMAIN OF c-erb82) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE. MEMBRANE STAINING IS IDENTIFIED. THEREFORE, c-erbB2 (HER-2/NEU) IS INTERPRITED AS NEGATIVE (SCORE 0). ER/PR RESULTS (""A4""). IMMUNOPEROXIDASE IDENTIFICATION or ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE ""A4"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOCALLY FOR PROGESTGERONE RECEPTOR (15%) BUT NOT FOR ESTROGEN. RECEPTOR. THEREFORE, PROGESTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROGEN RECEPTOR AS NEGATIVE. HER-2/NEU RESULTS (""A4""). AS PER THE REQUEST OF DR. c-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGEE. (BREAST CANCER) USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485. (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE. MEMBRANE STAINING IS IDINTIFIED. THEREFORE, c-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 0) .",BRCA,1,"The report explicitly mentions the presence of metastasis in one sentinel lymph node (1/9). According to the rules, an explicit mention of metastasis in a specific number of axillary lymph nodes indicates the corresponding N stage.",N1,18.0
683,TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491,1,"Diagnosis: Poorly differentiated invasive malignant tumor (tumor diameter 3.5 cm). with focal in situ spread and marked angioinvasion. In conjunction with the preliminary finding, this gives rise to the following tumor. classification: lobular carcinoma, NOS, G III, oT2N3aL1V1RX. (circle): Primary. pitial. Noted.",BRCA,3,"The report explicitly mentions that the tumor is pT2 (tumor diameter 3.5 cm) and pN3a (metastasis in 10 or more axillary lymph nodes). This matches the definition for N3 stage, so no need to use the highest possible N stage based on the provided information.",N3,19.0
960,TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34,1,"FINAL DIAGNOSIS: PART 1: LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/2) (see comment). PART 2: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION 3, NUCLEAR GRADE 2,. MITOTIC RATE 1; TOTAL SCORE 6/9). B. INVASIVE CARCINOMA MEASURES 2.2 CM IN GREATEST DIMENSION. C. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, SOLID TYPE WITH COMEDONECROSIS. D. DCIS IS PRESENT ADMIXED WITH INVASIVE COMPONENT AND COMPRISES <5% OF TOTAL TUMOR. VOLUME. E. MARGINS OF RESECTION ARE NEGATIVE FOR INVASIVE CARCINOMA AND DCIS, INVASIVE CARCINOMA. IS 5 MM FROM CLOSEST (POSTERIOR) MARGIN OF RESECTION. F. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. G. SKIN, NEGATIVE FOR TUMOR. H. INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. EQUIVOCAL FOR HER-2/NEU WITH A SCORE OF 2+, AND PER PREVIOUS PATHOLOGY REPORT (. NO AMPLIFICATION OF THE HER-2/NEU GENE WAS SEEN BY INTERFACE FISH ANALYSIS. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: Keratin stain. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO(i-). M STAGE, PATHOLOGIC: pma. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",BRCA,0,"The report explicitly mentions that 2 lymph nodes were examined and found to be negative for metastatic carcinoma (0/2). Therefore, the N stage is N0, as there is no regional lymph node metastasis.",N0,19.0
1153,TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF,0,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. !. Expected time of examination: up to 8 working days. Clinical diagnosis: Bifocal cancer of the right breast. Results of immunohistochemical examination: Tumour 1. No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein. stained using rabbit antibody Ventana PATHWAY HER-2/neu (485). Positive reaction in invasive cancerous cells (Score = 3+). Tumour 2. No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein. stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Positive reaction in invasive cancerous cells (Score = 3+). validated by: I. Macroscopic description: Right breast sized 26 x 19 x 5 cm with axillary tissues sized 11 x 8 x 2 and a skin flap of 24 x 2.5 cm. Tumour sized 1.6 x 1.5 x I.3 cm found on the boundary of lower quadrants, located 1.3 cm from the lower boundary, 1 cm from. the base and 4 cm from the skin. The other tumour present in the upper outer quadrant, sized 1.6 x 1.5 x 1.2 cm, removed by 0.1 cm from the base, 0.6 cm from. the skin and 3 cm from the upper boundary. Microscopic description: Both tumours: Carcinoma ductale invasivum NHG3 (3+3+2/ 12 mitoses /10 HPF, visual area diameter: 0.55mm). Few. foci of carcinoma ductale in situ (DCIS) (papillary type, with medium nuclear atypia and comedo necrosis of 5% of. the tumour). In situ lesions of the type carcinoma intraductale mamillae. Glandular tissue showing parenchymal atrophy. AXILLARY LYMPH NODES:Metastases carcinomatosae in lymphonodis (No III/X). page 2 / 2. Examination: Histopathological examination. Gender: F. Infiltratio telae perinodalis. Test result: Carcinoma ductale invasivum bifocale et ductale in situ mammae dextrae. Invasive bifocal ductal carcinoma and ductal. carcinoma in situ of the right breast. Metastases carcinomatosae in lymphonodis axillae (No III/X). Cancer metastases in axillary. lymph nodes (NHG3, pTlc, pNIa). Compliance valida.",BRCA,1,The report explicitly mentions 'Metastases carcinomatosae in lymphonodis (No III/X)' which indicates metastasis in 4-9 axillary lymph nodes. This corresponds to N2 stage.,N2,20.0
995,TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B,1,"FINAL DIAGNOSIS: RART SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. 1: CARCINOMA INVOLVING ONE LYMPH NODE (1/1). A. METASTATIC METASTATIC FOCUS MEASURES 3.0 CM IN GREATEST DIAMETER 0.1 (ENTIRE CM. LYMPH NODE). B. c. EXTRACAPSULAR EXTENSION IS IDENTIFIED MEASURING 0.2 X. PART 2: BREAST, LEFT, SIMPLE MASTECTOMY -. A. DUCTAL EPITHELIAL HYPERPLASIA. B. PREDOMINANTLY ADIPOSE BREAST PARENCHYMA. c. SKIN AND NIPPLE HISTOLOGICALLY UNREMARKABLE. PART 3: A. BREAST. INVASIVE RIGHT, DUCTAL MODIFIED CARCINOMA RADICAL 3.0 MASTECTOMY 3/3, CM NUCLEAR (GROSS) NOTTINGHAM PLEOMORPHISM - GRADE 2/3, MITOTIC 3 (COMBINED ACTIVITY NOTTINGHAM 3/3) WITH. TUBULE. LYMPHOPLASMACYTIC SCORE 8/9: INFILTRATE AND NECROSIS. B. DEFINITIVE LYMPHOVASCULAR. C. DUCTAL CARCINOMA IN SITU IS NOTIBENTIFIED. D. RESECTION MARGINS FREE. E. DUCTAL EPITHELIAL HYPERPLASIAL. F. G. SKIN TWENTY-TWO AND NIPPLE, LYMPH HISTOLOGICALLY NODES, NEGATIVE UNREMARKABLE FOR METASTATIC CARCINOMA (0/22). H. PATHOLOGIC STAGE (see comment): I. RECEPTOR STATUS (see comment). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 3.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 23. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 30.0 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): T STAGE, PATHOLOGIC: p12. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",BRCA,1,"The pathology report explicitly mentions metastasis in one axillary lymph node (pN1a), which corresponds to the N1 stage.",N1,21.0
